Tang; Tony P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tang; Tony P..The latest application filed is for "substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of fgfr tyrosine kinases".

Company Profile

23.28.34

Tang; Tony P. - Boulder CO
Tang; Tony P. - Boudler CO

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
KRas G12D inhibitors Grant 11,453,683 - Wang , et al. September 27, 2	2022-09-27
Substituted Pyrazolo[1,5-a]pyridine Compounds As Inhibitors Of Fgfr Tyrosine Kinases App 20220081438 - Blake; James F. ; et al.	2022-03-17
KRAS G12C inhibitors Grant 11,267,812 - Fischer , et al. March 8, 2	2022-03-08
Process For The Preparation Of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6- -diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-car- Bonitrile App 20210380609 - EARY; Charles Todd ; et al.	2021-12-09
Kras G12c Inhibitors App 20210269432 - FISCHER; John P. ; et al.	2021-09-02
Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6- -diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-car- bontrile Grant 11,098,064 - Eary , et al. August 24, 2	2021-08-24
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors App 20210186959 - Andrews; Steven W. ; et al.	2021-06-24
4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors Grant 11,028,093 - Allen , et al. June 8, 2	2021-06-08
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors Grant 10,953,005 - Andrews , et al. March 23, 2	2021-03-23
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant 10,881,652 - Andrews , et al. January 5, 2	2021-01-05
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors App 20200383966 - ANDREWS; Steven W. ; et al.	2020-12-10
Process For The Preparation Of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6- -diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-car- Bonitrile App 20200308194 - EARY; Charles Todd ; et al.	2020-10-01
Kras G12c Inhibitors App 20200308170 - Marx; Matthew Arnold ; et al.	2020-10-01
4,6-SUBSTITUTED-PYRAZOLO[1,5-a]PYRAZINES AS JANUS KINASE INHIBITORS App 20200291039 - Allen; Shelley ; et al.	2020-09-17
2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases Grant 10,766,881 - Andrews , et al. Sep	2020-09-08
Kras G12c Inhibitors App 20200262837 - Marx; Matthew Arnold ; et al.	2020-08-20
Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6- -diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-car- bonitrile Grant 10,745,419 - Eary , et al. A	2020-08-18
4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors Grant 10,730,880 - Allen , et al.	2020-08-04
KRas G12C inhibitors Grant 10,647,715 - Marx , et al.	2020-05-12
KRas G12C inhibitors Grant 10,633,381 - Blake , et al.	2020-04-28
Crystalline forms Grant 10,584,124 - Metcalf , et al.	2020-03-10
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant 10,555,944 - Andrews , et al. Feb	2020-02-11
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors App 20200030311 - ANDREWS; Steven W. ; et al.	2020-01-30
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant 10,441,581 - Andrews , et al. Oc	2019-10-15
2-aryl- And 2-heteroaryl-substituted 2-pyridazin-3(2h)-one Compounds As Inhibitors Of Fgfr Tyrosine Kinases App 20190300511 - Andrews; Steven W. ; et al.	2019-10-03
Kras G12c Inhibitors App 20190270743 - Marx; Matthew Arnold ; et al.	2019-09-05
Crystalline Forms App 20190263811 - Metcalf; Andrew T. ; et al.	2019-08-29
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors App 20190183886 - Andrews; Steven W. ; et al.	2019-06-20
4,6-SUBSTITUTED-PYRAZOLO[1,5-a]PYRAZINES AS JANUS KINASE INHIBITORS App 20190177328 - Allen; Shelley ; et al.	2019-06-13
Process For The Preparation Of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6- -diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-car- Bonitrile App 20190106438 - Eary; Charles Todd ; et al.	2019-04-11
Kras G12c Inhibitors App 20190062330 - Blake; James F. ; et al.	2019-02-28
2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases Grant 10,208,024 - Andrews , et al. Feb	2019-02-19
4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors Grant 10,189,845 - Allen , et al. Ja	2019-01-29
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant 10,172,845 - Andrews , et al. J	2019-01-08
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant 10,172,851 - Andrews , et al. J	2019-01-08
Serine/threonine kinase inhibitors Grant 10,154,995 - Blake , et al. Dec	2018-12-18
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant 10,144,734 - Andrews , et al. De	2018-12-04
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors Grant 10,137,124 - Andrews , et al. November 27, 2	2018-11-27
KRas G12C inhibitors Grant 10,125,134 - Blake , et al. November 13, 2	2018-11-13
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant 10,112,942 - Andrews , et al. October 30, 2	2018-10-30
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors App 20180148445 - Andrews; Steven W. ; et al.	2018-05-31
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors App 20180133207 - Andrews; Steven W. ; et al.	2018-05-17
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors App 20180133213 - Andrews; Steven W. ; et al.	2018-05-17
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors App 20180133200 - Andrews; Steven W. ; et al.	2018-05-17
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors App 20180134702 - Andrews; Steven W. ; et al.	2018-05-17
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors App 20180134703 - Andrews; Steven W. ; et al.	2018-05-17
Kras G12c Inhibitors App 20180072723 - Blake; James F. ; et al.	2018-03-15
4,6-SUBSTITUTED-PYRAZOLO[1,5-a]PYRAZINES AS JANUS KINASE INHIBITORS App 20170362240 - Allen; Shelley ; et al.	2017-12-21
Serine/threonine Kinase Inhibitors App 20170348310 - Blake; James F. ; et al.	2017-12-07
Serine/threonine kinase inhibitors Grant 9,763,942 - Blake , et al. September 19, 2	2017-09-19
2-aryl- And 2-heteroaryl-substituted 2-pyridazin-3(2h)-one Compounds As Inhibitors Of Fgfr Tyrosine Kinases App 20170260168 - Andrews; Steven W. ; et al.	2017-09-14
Serine/threonine Kinase Inhibitors App 20160303126 - Blake; James F. ; et al.	2016-10-20
Pyrimidyl cyclopentanes as Akt protein kinase inhibitors Grant 9,346,805 - Banka , et al. May 24, 2	2016-05-24
5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors Grant 9,328,091 - Leivers , et al. May 3, 2	2016-05-03
5H-CYCLOPENTA[d]PYRIMIDINES AS AKT PROTEIN KINASE INHIBITORS App 20150266852 - Leivers; Anna ; et al.	2015-09-24
5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors Grant 8,895,566 - Banka , et al. November 25, 2	2014-11-25
5h-cyclopenta[d]pyrimidines As Akt Protein Kinase Inhibitors App 20130085135 - Banka; Anna ; et al.	2013-04-04
Pyrimidyl Cyclopentanes As Akt Protein Kinase Inhibitors App 20130072500 - Banka; Anna ; et al.	2013-03-21
5H-cyclopenta[D]pyrimidines as AKT protein kinase inhibitors Grant 8,329,709 - Banka , et al. December 11, 2	2012-12-11
Compounds For Treating Neurodegenerative Diseases App 20120157448 - Cook; Adam ; et al.	2012-06-21
Compounds For Treating Neurodegenerative Diseases App 20120083501 - Hunt; Kevin W. ; et al.	2012-04-05
Pyrimidyl Cyclopentanes As Akt Protein Kinase Inhibitors App 20110053959 - Banka; Anna ; et al.	2011-03-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.